ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 766,95
0,06%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zealand Pharma AS (ZEAL)

  7. Zealand Pharma AS (ZEAL) Actualités

ZEAL

Zealand Pharma AS (ZEAL)

Zealand Pharma AS
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZEAL
DateHeureSourceTitreSymboleSociété
10/11/202215h00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Nine Months of 2022NASDAQ:ZEALZealand Pharma AS
08/11/202214h30GlobeNewswire Inc.Zealand Pharma to Participate in Upcoming Investor ConferencesNASDAQ:ZEALZealand Pharma AS
03/11/202209h00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
01/11/202217h00GlobeNewswire Inc.Zealand Pharma Announces Presentations at The Obesity Society Annual MeetingNASDAQ:ZEALZealand Pharma AS
11/10/202217h05GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Polar CapitalNASDAQ:ZEALZealand Pharma AS
10/10/202217h12GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Van Herk InvestmentsNASDAQ:ZEALZealand Pharma AS
07/10/202208h41GlobeNewswire Inc.Zealand Pharma completes registration of capital increaseNASDAQ:ZEALZealand Pharma AS
04/10/202222h07GlobeNewswire Inc.Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 millionNASDAQ:ZEALZealand Pharma AS
04/10/202217h05GlobeNewswire Inc.Zealand Pharma announces directed issue and private placement of approximately 4.5m new sharesNASDAQ:ZEALZealand Pharma AS
30/09/202222h15TipRanksNeedham Sticks to Their Buy Rating for Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
30/09/202222h00GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at September 30, 2022NASDAQ:ZEALZealand Pharma AS
30/09/202213h41TipRanksZealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive ResultsNASDAQ:ZEALZealand Pharma AS
30/09/202212h15GlobeNewswire Inc.Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)NASDAQ:ZEALZealand Pharma AS
21/09/202214h15GlobeNewswire Inc.Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)NASDAQ:ZEALZealand Pharma AS
19/09/202208h00GlobeNewswire Inc.Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE MeetingNASDAQ:ZEALZealand Pharma AS
14/09/202212h11TipRanksAnalysts’ Top Healthcare Picks: Zealand Pharma (ZEAL), POINT Biopharma Global (PNT)NASDAQ:ZEALZealand Pharma AS
13/09/202222h05GlobeNewswire Inc.Zealand Pharma grants warrants to employees in DenmarkNASDAQ:ZEALZealand Pharma AS
08/09/202222h05GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
07/09/202217h00GlobeNewswire Inc.Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:ZEALZealand Pharma AS
07/09/202208h00GlobeNewswire Inc.Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)NASDAQ:ZEALZealand Pharma AS
31/08/202221h30GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at August 31, 2022NASDAQ:ZEALZealand Pharma AS
24/08/202210h30GlobeNewswire Inc.Zealand Pharma Appoints Henriette Wennicke as Chief Financial OfficerNASDAQ:ZEALZealand Pharma AS
11/08/202219h30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
11/08/202215h00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Half of 2022NASDAQ:ZEALZealand Pharma AS
08/08/202222h30GlobeNewswire Inc.Updated notice to holders of ADSs regarding termination of Deposit AgreementNASDAQ:ZEALZealand Pharma AS
08/08/202222h05GlobeNewswire Inc.Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select MarketNASDAQ:ZEALZealand Pharma AS
04/08/202215h00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
14/07/202212h45TipRanksZealand Pharma (ZEAL) Receives a Buy from NeedhamNASDAQ:ZEALZealand Pharma AS
30/06/202215h44GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at June 30, 2022NASDAQ:ZEALZealand Pharma AS
15/06/202222h00GlobeNewswire Inc.Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilitiesNASDAQ:ZEALZealand Pharma AS
 Showing the most relevant articles for your search:NASDAQ:ZEAL

Dernières Valeurs Consultées

BIT
P20A67
NLBNPIT20A67 20240621 34...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés